TABLE 2.

Virulence genotypes and hemagglutination titers of clinical isolates

StrainGenotypeTiterFimH immunoblotc
papACEFGsfa/focDEfimHhlyAfyuAiutAkpsMTIIkpsMTIIIK1K5ibeAtraTPAIaHAbHA mannose
ASB1+++++++++128<2+
ASB2++++++64<2+
ASB3+++++++128<2+++
ASB4+++32<2+
ASB5++++++++128<2+
Acute1++++++++16<20
Acute2++++64<2+
Acute3+++++++64<2++
Acute4+++++++++32<2+
rUTI1+880
rUTI2+++++++2<2+
rUTI3++++++++82+
rUTI4+++++++++2<20
rUTI5++++++++++84+
Pyelo1++++1616+
Pyelo2++42+
Pyelo3++++++++88+
Pyelo4++++++++88+
UTI89++++++++++642++
CFT073+++++++1284++
% Prevalence406010050804070102045257070
  • a PAI, pathogenicity-associated island marker.

  • b HA, hemagglutination of guinea pig red blood cells. Values equal 2x, where x equals the last well of agglutination.

  • c Percent expression relative to UTI89 (0 = 0% to 49%; + = 50% to 99%; ++ = 100% to 149%; +++ = 150% to 199%).